Sharjah, UAE: Experts at Zulekha Hospital Sharjah have successfully treated a 51-year-old Egyptian patient who has been suffering for the last two years from rectal cancer and recurring metastasis (which is a spread caused by a cancerous tumour) using the latest CT-guided Percutaneous Microwave Ablation (MWA) Technique. The patient was unaware of the cancer spreading to various organs as she was able to carry out her normal daily routine with occasional discomfort only.
The patient was initially treated with a surgery in Egypt. Post-surgery she underwent a PET (Positron Emission Tomography) scan in which the liver metastasis was diagnosed. Her treating doctor had recommended medication for six months without immunotherapy, further evaluation revealed that the liver metastasis had progressed and complication arose due the recurrence of rectal carcinoma (cancer).
The patient had undergone another surgery for liver metastasectomy and continued her treatment. On her follow up, the doctors discovered new liver metastasis by investigations (PET scan and MRI). Burdened by the recurrence of the disease, she consulted Surgical Oncologist & General Surgeon Dr. Fadi Alnehlaoui who was supported by Dr. Amro Adnan Kabakbjy, Specialist Interventional Radiologist at Zulekha Hospital Sharjah.
Without delay, the tumour board team of experts at the hospital including medical oncologists, radiologists and surgeons discussed the course of action and doctors carried out the CT-guided Percutaneous Microwave Ablation (MWA) as the case is delicate following a previous hepatic surgery. This technique is the recent advent in treating metastatic cancers and is effective reliable and minimally invasive method of treatment. A week after the procedure was performed, the patient was discharged and advised to be on regular diet, avoiding excessive strain on her body.
Dr. Alnehlaoui said: “We are glad we are managing some rare and complex cases with the latest available technology and expertise. The fact that we could treat this complicated case with a minimal invasive procedure is rewarding and we will be ensuring patient centric care at every step. The team assured a positive outcome from this minimal invasion procedure and the patient was pleased to be discharged after only one week following the surgery.”
The surgery not only is a primary treatment, but also as adjunctive therapy to external radiation. The hospital is keen on evaluating and managing complex cases across multiple disciplines and creating Centres of Excellence, oncology being a focus area as well. The facilities at the hospital have been upgraded to enable the medical teams to be able to support unforeseen complexities.
About Zulekha Healthcare Group
The Zulekha Hospital brand is part of the Zulekha Healthcare Group, and is among the forerunners in UAE healthcare for 25 years now.
Today the Zulekha Healthcare group includes three multidisciplinary hospitals with two in the UAE in Dubai and Sharjah, and the third in Nagpur, India. The Group also has four UAE medical centres and three pharmacies providing specialized treatments in over 25 disciplines.
Zulekha Hospital has received extensive recognition for its commitment towards quality care and sustainable business practices, such as Dubai Quality Appreciation Award, Dubai Quality Award, Mohammed Bin Rashid Al Maktoum Business Excellence Award, underling a commitment to providing high quality healthcare to patients and society at large.
For more information please visit: www.zulekhahospitals.com
© Press Release 2018